It is likely that Therasense is the main reason that supplemental examination filings are so low and may not ramp up any time in the near future. Eugene Perez and Chad Rink of Birch Stewart Kolasch & Birch report.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Birch Stewart Kolasch & Birch, USPTO, US Patent and Trademark Office, patent, AIA, supplemental examination, Therasense
